Société Française de Toxicologie
Menu icoMenu232White icoCross32White

Ajoutez un logo, un bouton, des réseaux sociaux

Cliquez pour éditer
  • Société Française de Toxicologie
  • Actualités ▴▾
    • Actualités 2025
    • Actualités 2024
    • Actualités 2023
  • La SFT ▴▾
    • Notre histoire
    • Les statuts
    • Les membres du Bureau
  • Adhérer et cotiser ▴▾
    • Adhérer à la SFT
    • Cotiser à la SFT
  • Le congrès 2025 ▴▾
    • Sponsors
    • Le programme
    • Inscriptions
    • Posters
    • Où et quand ?
    • Photos
  • Les webinaires de la SFT ▴▾
    • 2025
    • 2024
    • 2022
    • 2021
  • Autres événements ▴▾
    • 2025
    • 2026
  • Registre Européen des toxicologues (ERT) ▴▾
    • Généralités
    • 1ère demande d'inscription
    • Renouvellement d'inscription
  • Jeunes toxicologues ▴▾
    • Bourses de congrès
    • Prix de thèse
    • CFJTox
  • Cours et formation continue ▴▾
  • Offres d'emploi ▴▾
  • Archives des congrès de la SFT ▴▾
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • Et avant...
  • Se connecter
  • Actualités 2025
  • Actualités 2024
  • Actualités 2023
  • Notre histoire
  • Les statuts
  • Les membres du Bureau
  • Adhérer à la SFT
  • Cotiser à la SFT
  • Sponsors
  • Le programme
  • Inscriptions
  • Posters
  • Où et quand ?
  • Photos
  • 2025
  • 2024
  • 2022
  • 2021
  • 2025
  • 2026
  • Généralités
  • 1ère demande d'inscription
  • Renouvellement d'inscription
  • Bourses de congrès
  • Prix de thèse
  • CFJTox
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Et avant...
Retour

Comparative in vitro hepatic enzyme assay and species-specific TH modeling

Comparative in vitro hepatic enzyme assay and species-specific thyroid hormones modeling show that cinmethylin has no endocrine disrupting potential

Authors: N. Daguès, S. Melching-Kollmuss, I. Fegert, C. Gomes

BASF SE, Limburgerhof, Germany

Cinmethylin is a new herbicide developed for the selective pre-emergence control of many annual grass weeds. In toxicological studies, cinmethylin induces thyroid histopathological and hormone effects in the rat secondary to liver enzyme induction. To evaluate the human relevance of the thyroid effects, a comparative in vitro hepatic enzyme assay was conducted in rat and human primary hepatocytes, as recommended in the ECHA/EFSA Guidance for the identification of endocrine disruptors (EC 2018/605). Expression of Phase I (CYP) and Phase II (UGT) enzymes were measured after 7 days of exposure to cinmethylin. In addition, a physiologically-based kinetic (PBK) model has been developed to simulate cinmethylin effects on thyroid hormones homeostasis in rats and humans.

Cinmethylin induced CYP2B and CYP3A in rat and human hepatocytes, with a slightly more pronounced effect in male than in female donors for both species. Basal T4-UGT activity in human was 5 to 7 times lower than that in the rat and delta T4-UGT activity showed dose-related increases in cinmethylin-treated rat hepatocytes while no relevant changes were seen in human hepatocytes. The PBK model predicts no effect on the T3 and T4 concentrations and only a minor increase of TSH levels in human, when considering a worst-case exposure scenario unlikely to be achieved in real-life situations.

In conclusion, the interspecies comparative analysis using a combination of in vitro and in silico models allowed 1) to confirm that the thyroid changes observed in vivo in the rat exposed to cinmethylin were secondary to liver enzyme induction and 2) that this mode of action is not relevant to humans. Cinmethylin is therefore devoid of any endocrine disrupting potential.

icoLinkedin35Color icoComment35Color
icoLinkedin35Color icoComment35Color
0 commentaire(s)
ou
Connectez-vous
Aucun commentaire pour le moment.
Consultez également
Container closure system of a drug-device combination product

Container closure system of a drug-device combination product

Biological evaluation and management of changes for a container closure system of a drug-device...

23 novembre 2025
iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: A High-Accuracy QSAR Predicting Thyroid Receptor Disruption as a First Step Toward...

23 novembre 2025
COSMETICK digital tool

COSMETICK digital tool

Analysis of the toxicological profiles of cosmetic ingredients and risks for cosmetic product:...

23 novembre 2025
Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on in vitro NIS, TPO, and DIO1-2-3 activitiesAudrey Baze1,...

23 novembre 2025
Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates using non-negative...

23 novembre 2025
NAMs for evaluating DART potential

NAMs for evaluating DART potential

New approach methodologies for evaluating DART potential: Review on state of the art,...

23 novembre 2025
Hôpital Fernand-Widal - 200 rue du faubourg Saint-Denis - 75475 Paris Cedex 10 / Contact : sft.secretariat@gmail.com
icoLinkedin24Color
  • Plan du site
  • Licences
  • Mentions légales
  • CGUV
  • Paramétrer les cookies
  • Se connecter
  • Propulsé par AssoConnect, le logiciel des associations Professionnelles